Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Andrew Steinerman
Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q2 (7 quarters).
- Questions
- 40on tracked calls
- Challenge rate
- 8%3 of 40 questions
- Companies
- 7questioned at least once
- Reporting periods
- 7with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 40 of 40 questions from 7 companies
EFXEquifax12 questions · 7 reporting periods · 0 of 12 challenging
Calendar 2026 Q2
Mortgage revenues in USIS were up 60% in 1Q, up 40% in 2Q. Can you just sort of walk us through the bridge
Show response
Management attributed the deceleration to a weakening mortgage market and a tougher pre-qual share comp.
Calendar 2026 Q1
I wanted to ask about EWS mortgage revenue outperformance. What did you see in the first quarter?
Show response
Management addressed the question directly with specific data points.
Calendar 2025 Q4
Makes sense. Thank you.
Show response
Management addressed the question directly with specific data points.
Hi, Mark. I wanted to think a little more about Slide 11 and proprietary data.
Show response
Management addressed the question directly with specific data points.
Calendar 2025 Q3
John, could you just go over a little bit more the general corporate expense line in the third quarter and what's drivin
Show response
Management addressed the question directly with specific data points.
Based on the higher revenue?
Show response
Management addressed the question directly with specific data points.
Calendar 2025 Q2
Good. Thanks, John.
Show response
Management addressed the question directly with specific data points.
Hi. Two questions. First one is just what is mortgage revenues as a percentage of total revenues in the second quarter j
Show response
Management addressed the question directly with specific data points.
Calendar 2025 Q1
Hi, John. Just two questions. One is, could you just give us in the quarter just reported the percentage of U.S.
Show response
Management addressed the question directly with specific data points.
21% is a percent of mortgage revenue. It's a percent of mortgage revenue.
Show response
Management addressed the question directly with specific data points.
Calendar 2024 Q4
Okay. Thank you.
Show response
Management addressed the question directly with specific data points.
Hi. Two quick ones on mortgage. The first one is, John, could you just tell us what mortgage revenues were as a percenta
Show response
Management addressed the question directly with specific data points.
SPGIS&P Global6 questions · 6 reporting periods · 1 of 6 challenging
Calendar 2026 Q2
So just tell us a little bit more about how GTS revenues are impacted by volatility.
Show response
Eric explained the volatility mechanic directly and confirmed the upstream software divestiture is now reflected in the organic constant currency guide.
Calendar 2026 Q1
What was the organic ACV growth in the first quarter for MI? And then also remind us on the Ratings side
Show response
Eric confirmed ACV growth around 6%, in line with subscription revenue growth. Clarified bank loan repricing is not included in billed issuance.
Calendar 2025 Q3
if you could help us compare With Intelligence to BlackRock's Preqin, who I see as the closest peer in terms of relative data coverage across asset classes
Show response
Martina described With Intelligence as multi-asset class covering 30,000 managers and investors with unique family office data. Emphasized data quality and acceleration of organic private markets initiatives.
Calendar 2025 Q2
I surely saw and heard you say that you pushed up the '25 Rating revenue assumption really by just the second quarter outperformance. That does surprise me a little bit
Show response
Explained prudence based on potential volatility flare-ups, flat H2 refi comps, limited pull-forward assumptions, and flat M&A year-over-year. Acknowledged upside risk possibility.
Calendar 2025 Q1
what's the share count implied in the 2025 guide? And did it change since February? And secondly, you talk a lot about the strong balance sheet and the share buyback activity
Show response
Eric deferred on specific share count calculation. Martina ruled out transformative M&A, emphasizing organic growth with openness to small tuck-in acquisitions aligned with strategic themes.
Calendar 2024 Q4
do you feel like the ratings revenue market has entered a period of kind of, let's call it, more regular growth over the next few years
Show response
Confirmed market volumes back to or above 2021 highs. Noted 2025 comp is difficult, with prudent and modest expectations for M&A and opportunistic issuance.
TRIThomson Reuters Corporation5 questions · 5 reporting periods · 0 of 5 challenging
Calendar 2026 Q2
how you guys are thinking about this going into the back half
Show response
Rohan Kalra (on for Andrew Steinerman) asked on LLM costs and pricing model; Hasker said agentic solutions are token-efficient, Thomson gives a cost advantage, and TR is considering a consumption-based pricing component with infrastructure investments to support it next year.
Calendar 2026 Q1
I just wanted to know within the revenue guide, particularly for legal professionals for the year, what's assumed in terms of the government practice
Show response
Eastwood expects government growth subdued near term, improving toward end of 2026 as cancellations lap. CoCounsel Next will contribute some revenue in late 2026 but larger contribution in 2027 due to rev rec timing.
Calendar 2025 Q4
Are these clients consuming more or less content? And spending more or less time on Westlaw and why?
Show response
Steve said too early for like-for-like usage comparison but penetration is growing. AI will create complex legal issues driving headline demand. Expects lawyers to use CoCounsel as first and last tool of the day. Mike declined to break down Q1 guidance by segment, consistent with prior practice.
Calendar 2025 Q2
Is Westlaw Advantage a separate module from Precision, meaning you have to buy the agentic Deep Research capabilities in addition
Show response
David confirmed Westlaw Advantage requires an upgrade subscription tier that includes Deep Research as the crown jewel. CoCounsel Legal provides a much more integrated single experience.
Calendar 2025 Q1
you talked about expense timing maybe lower expenses in the first quarter getting shifted. So if you could tell us, how much expenses shifted
Show response
Mike explained Q1+Q2 margins average to ~39% consistent with full year. Steve noted end user adoption is healthy, customer success investments ramping under leaders from S&P and ServiceNow.
VRSKVerisk5 questions · 5 reporting periods · 1 of 5 challenging
Calendar 2026 Q2
have you assumed a low level or a typical level of hurricane activity when you consider the full 2026 revenue guide
Show response
Mann confirmed an average weather year is the base case and framed lighter activity as a contained transactional risk within the guidance range.
Calendar 2025 Q3
auto underwriting growth of their policies has been decelerating. That's kind of been well documented during earnings season. And I thought that might be a headwind as well
Show response
Elizabeth Mann clarified auto business has no premium linkage and shopping activity is stable. Lee added that improved rate adequacy has reduced non-rate action opportunities.
Calendar 2025 Q2
Could you just tell us who do they compete with? I'm assuming you're going to say ServiceTitan. But if that's true, how does AccuLynx distinguish itself?
Show response
Lee Shavel identified ServiceTitan and JobNimbus as competitors, noting AccuLynx differentiates through roofing-specific specialization in materials, process, and job management.
Calendar 2025 Q1
Do you feel like D&A as a percentage of revenues will kind of stay in this range going forward from here? Like is there a bias upwards?
Show response
Elizabeth Mann attributed current D&A to long-term builds (Core Lines Reimagine, next-gen financial models) being placed into service; expects D&A growth to moderate. Lee clarified ROIC methodology excludes D&A.
Calendar 2024 Q4
One, is there any share buyback in the guide? Two, the interest expense looks materially stepped-up to me. Like, are you making an assumption about the planned refi in that interest assumption?
Show response
Elizabeth Mann confirmed buyback is assumed, explained interest step-up from 2024 refinancing, and attributed D&A increase to project investment and capitalization timing.
CTASCintas4 questions · 4 reporting periods · 0 of 4 challenging
Calendar 2025 Q4
I just didn't quite get a compilation if [ ad stops ] are changed year-over-year
Show response
Ad stops/current customer growth very stable, if anything slightly positive. Q2 acquisition impact was 70bps; second half should assume about half that (30-35bps) with normal tail-off.
Calendar 2025 Q2
I just wanted to get a sense of how the current quarter started, just what's already kind of behind us in June, in the first couple of weeks of July
Show response
FY2026 start consistent with expectations and reflected in guidance. No change to go-to-market strategy. Vertical strategy performing well over 5-10 years.
Calendar 2025 Q1
what was energy and fuel cost as a percentage of revenues in the just reported third quarter
Show response
Energy costs flat at 1.7% of revenue. Q4 organic implied to be normal seasonal pattern with ~40bps FX headwind and ~90bps M&A impact.
Calendar 2024 Q4
could you just give us a sense if price realization has kind of now returned to the long-term average increase
Show response
Confirmed price increases back to historical levels as inflation declined. Ad stops showed no significant changes. New business remains strong.
IRMIron Mountain4 questions · 4 reporting periods · 0 of 4 challenging
Calendar 2026 Q1
if there's any change of where you're spending your CapEx for the year? And do you feel like your data center growth
Show response
CEO confirmed no capital constraints on data center growth with 400 megawatts energizing over next 2 years. CFO reiterated CapEx slightly down from last year with vast majority pre-leased to high credit quality tenants.
Calendar 2025 Q4
could you tell us if there are any meaningful restructuring charges to consider for 2026?
Show response
Barry confirmed zero restructuring charges in 2026. ~$1.8B of $2.0B growth CapEx goes to data center. Cash interest ~$905M, cash taxes up ~$20M YoY.
Calendar 2025 Q3
Could you comment anything on kind of really forward-looking CapEx targets kind of multiyear?
Show response
Bill said IRM targets inference and cloud, not LLM campus build-outs. Data center CapEx expected to gradually rise with pre-leased backlog growth.
Calendar 2024 Q4
I wanted to dive a little bit further into your prepared remarks about organic storage revenues being down sequentially in the fourth quarter
Show response
Barry attributed sequential decline to FX ($10M headwind) and intentional consumer storage profitability focus. Core records business was up sequentially.
Show 1 more company
MCOMoody's Corporation4 questions · 4 reporting periods · 1 of 4 challenging
Calendar 2026 Q1
you specifically said you're reshaping the portfolio. I was just wondering if that's sort of the past
Show response
Heuland explained portfolio reshaping includes recent divestitures and internal resource reallocation toward higher-growth areas like lending, decision grade data, and insurance underwriting.
Calendar 2025 Q4
I also want to understand how they affect the MA ARR figure
Show response
Noémie detailed: Learning Solutions creates ~2pp headwind to MA revenue growth (90% one-time), broadly neutral to MA margin (30bp dilution). Regulatory Reporting (not yet in guide, expected to close 2026) creates additional ~2pp MA revenue headwind, 100bp tailwind to MCO adjusted expense growth, $0.05-$0.10 EPS impact. ARR adjusted to eliminate divestiture effects.
Calendar 2025 Q3
the way they portrayed it, was for US companies that there was a decline in refi walls
Show response
Rob clarified article cited only US spec-grade subset. Noted yield curve steepening shortened average tenors, pushing significant maturities beyond 4-year window. This will ultimately be positive for refinancing needs.
Calendar 2024 Q4
I just wanted to talk about the contribution of M&A in the quarter for both MA and MIS and also going forward is the Cape acquisition and the guide
Show response
Noémie confirmed M&A contributed only 25 bps to MA revenue in 2024. For 2025, Tape Analytics tailwind roughly offset by FX headwinds making net M&A impact immaterial.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| EFX Equifax | 12 | 0%none of 12 questions |
| SPGI S&P Global | 6 | 17%1 of 6 questions |
| TRI Thomson Reuters Corporation | 5 | 0%none of 5 questions |
| VRSK Verisk | 5 | 20%1 of 5 questions |
| CTAS Cintas | 4 | 0%none of 4 questions |
| IRM Iron Mountain | 4 | 0%none of 4 questions |
| MCO Moody's Corporation | 4 | 25%1 of 4 questions |
- EFXEquifax · 12 questions0%none of 12 questions
- SPGIS&P Global · 6 questions17%1 of 6 questions
- TRIThomson Reuters Corporation · 5 questions0%none of 5 questions
- VRSKVerisk · 5 questions20%1 of 5 questions
- CTASCintas · 4 questions0%none of 4 questions
- IRMIron Mountain · 4 questions0%none of 4 questions
- MCOMoody's Corporation · 4 questions25%1 of 4 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q4 | 7 | 0%none of 7 questions | 6 |
| 2025 Q1 | 6 | 0%none of 6 questions | 5 |
| 2025 Q2 | 6 | 17%1 of 6 questions | 5 |
| 2025 Q3 | 6 | 33%2 of 6 questions | 5 |
| 2025 Q4 | 6 | 0%none of 6 questions | 5 |
| 2026 Q1 | 5 | 0%none of 5 questions | 5 |
| 2026 Q2 | 4 | 0%none of 4 questions | 4 |
- 2024 Q47 questions · challenge rate 0% (none of 7 questions) · 6 companies
- 2025 Q16 questions · challenge rate 0% (none of 6 questions) · 5 companies
- 2025 Q26 questions · challenge rate 17% (1 of 6 questions) · 5 companies
- 2025 Q36 questions · challenge rate 33% (2 of 6 questions) · 5 companies
- 2025 Q46 questions · challenge rate 0% (none of 6 questions) · 5 companies
- 2026 Q15 questions · challenge rate 0% (none of 5 questions) · 5 companies
- 2026 Q24 questions · challenge rate 0% (none of 4 questions) · 4 companies
Topics
Topics tagged on this analyst’s questions.
- Revenue Growth15
- Demand10
- Credit9
- Cloud & AI8
- M&A7
- Guidance Reliability6
- Cost Pressure5
- Capital Allocation5
- Competitive Dynamics5
- Capex Investment4
Show all 17 topics
- Macroeconomic3
- Pricing3
- Product Launch1
- Subscriber Growth1
- Regulation Policy1
- Innovation & R&D1
- Margin1